Abstract
Dysregulation of microRNAs (miRNAs) is associated with the occurrence and development of clear cell renal cell carcinoma (ccRCC) through their participation in a number of critical biological processes. Therefore, an in-depth investigation into miRNAs and their biological roles within ccRCC may provide useful insights and lead to the identification of novel therapeutic methods for patients with ccRCC. miRNA-599 (miR-599) serves critical roles in different types of human cancer. However, the expression pattern, biological function and molecular mechanism of miR-599 in ccRCC remain unknown. The present study aimed to detect the expression level of miR-599 in ccRCC, examine its effect on ccRCC progression and further explore the possible underlying mechanisms. It was observed that miR-599 was significantly underexpressed in ccRCC tissues and cell lines compared with the control. Functional assays revealed that restored expression of miR-599 restricted the proliferation and invasion of ccRCC cells. Bioinformatics analysis, luciferase reporter assay, reverse transcription-quantitative polymerase chain reaction and western blot analysis demonstrated that high-mobility group AT-hook 2 (HMGA2) was a direct target of miR-599 in ccRCC. HMGA2 knockdown simulated the suppressive effects caused by miR-599 overexpression in ccRCC. Recovered HMGA2 expression partially rescued the miR-599-mediated inhibition of ccRCC proliferation and invasion. These results suggest that miR-599 may serve tumour suppressive roles in ccRCC by directly targeting HMGA2, indicating that miR-599 may have potential as a treatment for patients with ccRCC.
Author supplied keywords
Cite
CITATION STYLE
Zhao, H., Zhao, H., Xia, X., & Liu, X. (2018). Microrna-599 targets high-mobility group at-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma. Molecular Medicine Reports, 17(5), 7451–7459. https://doi.org/10.3892/mmr.2018.8755
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.